SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $QNCX #biotech–Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, a virtual event, on Wednesday, February 12, 2025 beginning at 2:00 p.m. Easter
More in Trade Show
Trade Show
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
JUPITER, Fla.–(BUSINESS WIRE)–Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ...
Trade Show
US Foods to Webcast Presentation at the CAGNY 2025 Conference
ROSEMONT, Ill.–(BUSINESS WIRE)–US Foods Holding Corp. (NYSE: USFD) today announced that Dave Flitman, ...
Trade Show
NRC Health ranked #1 Best in KLAS for Healthcare Experience Management
LINCOLN, Neb.–(BUSINESS WIRE)– #BIK–NRC Health, a leader in advanced technology and data-driven insights ...
